A
Aldena Therapeutics
Developing therapies for Dermatology, discovering and enabling delivery of nucleic acid therapies in conditions with high burden to patients
At a glance
- Status
- Operational
- Employees
- 6
- Open positions
- None listed
- Dealroom signal
- 18.5/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Client focus
- B2B
- Investment activity
- 5 companies, latest Feb 2024
- Capital deployed
- —
- Preferred round
- MERGER
- Links
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| MERGER✓Other financing | Feb 2024 | $0 | — | Graegis Pharmaceuticals · Granular Therapeutics · Klirna Biotech · Nira Biosciences | ↗ |
| EARLY VC✓Equity / VC | Mar 2023 | $30M | $120M | Medicxi | ↗ |
Growth signals
Aldena Therapeutics's team grew 20% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Granular TherapeuticsUnited KingdomPrecision biologic therapies targeting mast cell-driven diseases
→
Graegis PharmaceuticalsLondon, United Kingdom
→
Aldena Therapeutics in the Boston ecosystem
The Aldena Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Medicxi
Other known investors6 additional known investors
Graegis Pharmaceuticals
Granular Therapeutics- KBKlirna Biotech
- NBNira Biosciences
- VTVimela Therapeutics
Alys Pharmaceuticals
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Aldena Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Aldena Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









